Skip to content
gbanco4 edited this page Dec 19, 2024 · 23 revisions

bibliography: 'morinlab.bib' csl: 'NLM.csl' link-citations: true

[[TOC]]

Overview

MGA acts as a transcriptional repressor and interacts with MYC, a well-known oncogene. Mutations in MGA have been described in DLBCL.[@jalladesExomeSequencingIdentifies2017] One study suggested MGA mutations were more common in DLBCLs in patients of African ancestry.[@reddyGeneticFunctionalDrivers2017] The mutation pattern in MGA is consistent with a role as a tumour suppressor gene.

Relevance tier by entity

Entity Tier Description
MZL 2 relevance in MZL not firmly established[@jalladesExomeSequencingIdentifies2017]
DLBCL 1 high-confidence DLBCL gene[@reddyGeneticFunctionalDrivers2017]

Mutation incidence in large patient cohorts (GAMBL reanalysis)

include:DLBCL_MGA.md

Mutation pattern and selective pressure estimates

include:dnds_MGA.md

include:browser_MGA.md

Expression

include:mermaid_MGA.md

References

Disclaimer

The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.

In particular, let us know if you feel that an important citation is missing or if a paper has been cited incorrectly.

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format for any purpose, even commercially.

Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.

Clone this wiki locally